Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 22, 2024

SELL
$122.71 - $146.91 $408,501 - $489,063
-3,329 Reduced 11.99%
24,445 $3.49 Million
Q1 2024

May 10, 2024

BUY
$102.11 - $135.92 $2.84 Million - $3.78 Million
27,774 New
27,774 $3.57 Million
Q4 2023

May 21, 2024

SELL
$87.78 - $105.45 $129,299 - $155,327
-1,473 Reduced 5.3%
26,301 $2.72 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $233B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Burr Financial Services, LLC Portfolio

Follow Burr Financial Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Burr Financial Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Burr Financial Services, LLC with notifications on news.